BIOMEA FUSION INC. - COMMON STOCK

Biomea Fusion to Present New Preclinical Data Showing BMF-219’s Strong Activity in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) Tumor Models at ASCO 2022

26 مايو 2022 18:30:00 بحسب Nasdaq GlobeNewswire

Biomea Fusion to Attend H.C. Wainwright Global Investment Conference

20 مايو 2022 13:30:00 بحسب Nasdaq GlobeNewswire

Biomea Fusion Announces IND Candidate Selection: BMF-500, a Potential Best-in-Class Oral Covalent Inhibitor of FLT3

19 مايو 2022 08:00:00 بحسب Nasdaq GlobeNewswire

Biomea Fusion Reports First Quarter 2022 Financial Results and Business Highlights

16 مايو 2022 07:30:00 بحسب Nasdaq GlobeNewswire

Biomea Fusion to Participate in Bank of America Securities 2022 Healthcare Conference

09 مايو 2022 16:30:00 بحسب Nasdaq GlobeNewswire

Biomea Fusion Announces Acceptance of Multiple Abstracts at the 2022 ASCO Annual Meeting

27 أبريل 2022 16:00:00 بحسب Nasdaq GlobeNewswire

Biomea Fusion Reports Preclinical Data on BMF-219 and Trial in Progress Presentations at AACR 2022 Annual Meeting

08 أبريل 2022 13:00:00 بحسب Nasdaq GlobeNewswire

Biomea Fusion Announces Acceptance of Late Breaking Presentation of Lead Menin Inhibitor BMF-219 in Diabetes at ADA 82nd Scientific Sessions 2022

06 أبريل 2022 17:00:00 بحسب Nasdaq GlobeNewswire

Biomea Fusion to Present at Oppenheimer’s 32nd Annual Virtual Healthcare Conference

15 مارس 2022 08:30:00 بحسب Nasdaq GlobeNewswire

Biomea Fusion Announces Upcoming Presentations of Preclinical Data in Diffuse Large B-Cell Lymphoma, Multiple Myeloma, and Several KRAS Mutant Solid Tumors for BMF-219 at AACR Annual Meeting 2022

08 مارس 2022 18:15:00 بحسب Nasdaq GlobeNewswire

Biomea Fusion Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Highlights

28 فبراير 2022 16:05:01 بحسب Nasdaq GlobeNewswire

Biomea Fusion Announces Appointment of Steve Morris, M.D. as Chief Medical Officer

01 فبراير 2022 06:30:00 بحسب Nasdaq GlobeNewswire

Biomea Fusion Announces First Patient Dosed

25 يناير 2022 08:30:00 بحسب Nasdaq GlobeNewswire

Biomea Fusion Announces Participation at the H.C. Wainwright 2022 BioConnect Conference

11 يناير 2022 08:30:00 بحسب Nasdaq GlobeNewswire

Biomea Fusion Announces 2022 Clinical Development Plan to Initiate Studies in up to Seven Different Tumor Types and in Diabetes for BMF-219

10 يناير 2022 08:30:01 بحسب Nasdaq GlobeNewswire

Biomea Fusion Releases Pre-Clinical Data with BMF-219 in Diabetes

06 يناير 2022 08:30:00 بحسب Nasdaq GlobeNewswire

Biomea Fusion Moves into New Headquarters and Expands R&D Facility

04 يناير 2022 13:30:14 بحسب Nasdaq GlobeNewswire

Biomea Fusion to Present at the 40th Annual J.P. Morgan Healthcare Conference

21 ديسمبر 2021 08:00:01 بحسب Nasdaq GlobeNewswire

Biomea Fusion to be added to NASDAQ Biotechnology Index

14 ديسمبر 2021 08:00:01 بحسب Nasdaq GlobeNewswire

Biomea Fusion to Participate in Two Upcoming Investor Conferences

10 نوفمبر 2021 14:00:00 بحسب Nasdaq GlobeNewswire